Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received a consensus rating of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $19.4545.

A number of research firms recently weighed in on SGRY. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a report on Friday, August 21st. Royal Bank Of Canada dropped their price objective on Surgery Partners from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, August 11th. TD Cowen boosted their price objective on Surgery Partners from $17.00 to $19.00 and gave the company a “buy” rating in a research report on Tuesday, August 11th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $18.00 target price on shares of Surgery Partners in a research note on Tuesday, August 11th. Finally, Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th.

Insider Activity

In related news, Director Teresa Deluca bought 10,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. This trade represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Surgery Partners

Several institutional investors have recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its stake in Surgery Partners by 239.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after buying an additional 2,051 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Surgery Partners in the second quarter valued at approximately $38,000. Fifth Third Bancorp boosted its stake in shares of Surgery Partners by 5,324.0% in the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after acquiring an additional 3,993 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in shares of Surgery Partners by 45,640.0% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock worth $49,000 after acquiring an additional 2,282 shares during the last quarter. Finally, Aquatic Capital Management LLC purchased a new stake in shares of Surgery Partners during the third quarter worth approximately $121,000.

Surgery Partners Price Performance

SGRY opened at $13.69 on Monday. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $23.44. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The company has a fifty day moving average of $15.49 and a two-hundred day moving average of $14.39. The stock has a market capitalization of $1.79 billion, a price-to-earnings ratio of -19.56, a PEG ratio of 4.22 and a beta of 1.92.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The business had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. During the same period in the prior year, the company posted $0.17 EPS. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, research analysts expect that Surgery Partners will post 0.22 earnings per share for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.